187 related articles for article (PubMed ID: 9091612)
1. From vascular protection to secondary prevention in cardiovascular diseases. Proceedings of satellite symposium to the 16th Scientific Meeting of the International Society of Hypertension. Glasgow, United Kingdom, 23 June 1996.
J Hypertens Suppl; 1996 Dec; 14(6):S1-53. PubMed ID: 9091612
[No Abstract] [Full Text] [Related]
2. The role of ACE inhibitors in current clinical practice. The place of perindopril: a review. Proceedings of two symposia. 8 November and 15 November, 1989.
J Hum Hypertens; 1990 Oct; 4 Suppl 4():1-73. PubMed ID: 1980931
[No Abstract] [Full Text] [Related]
3. [Hypertension, heart failure, myocardial infarction, secondary prevention: the role of perindopril].
Rapezzi C; Ciliberti P; Graziosi M; Riva L
Ital Heart J; 2005 Nov; 6 Suppl 7():40S-47S. PubMed ID: 16485516
[TBL] [Abstract][Full Text] [Related]
4. [Symposium on future prospects of angiotensin converting enzyme. Presentation of perindopril, a new and potent ACE inhibitor. Perindopril exerts an efficacious and rapid inhibition of ACE in plasma as well as in tissues].
Med Clin (Barc); 1991 Apr; 96(16):suppl 2 p.. PubMed ID: 2051826
[No Abstract] [Full Text] [Related]
5. [The use of perindopril (prestarium) in arterial hypertension].
Filatova NP
Ter Arkh; 1995; 67(9):81-3. PubMed ID: 7495054
[No Abstract] [Full Text] [Related]
6. [Hypertension and the renin-angiotensin system. The role of perindopril. 1st international Coversyl symposium. Paris, 29 October 1988. Proceedings].
Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():1-94. PubMed ID: 2505707
[No Abstract] [Full Text] [Related]
7. Symposium: Systemic Hypertension: Contribution of Trandolapril, a New Angiotensin-Converting Enzyme Inhibitor, Toward Patient Protection. 14th scientific meeting of the International Society of Hypertension. Madrid, Spain, June 13, 1992.
Am J Cardiol; 1992 Oct; 70(12):1D-66D. PubMed ID: 1357952
[No Abstract] [Full Text] [Related]
8. Perindopril and reference antihypertensives.
Thurston H
S Afr Med J; 1991 Oct; Suppl():10-4; discussion 15. PubMed ID: 1925813
[No Abstract] [Full Text] [Related]
9. Effects of perindopril on structural and functional changes in hypertensive arteries.
Thomas JR; Asmar RG; Safar ME
S Afr Med J; 1991 Oct; Suppl():6-9. PubMed ID: 1925815
[No Abstract] [Full Text] [Related]
10. [Study PROTECT (Perindopril Regression of Vascular Thickening). European Community Trial].
Tarentini Trojani F
Clin Ter; 1994 Nov; 145(11):411-2. PubMed ID: 7889727
[No Abstract] [Full Text] [Related]
11. Perindopril/indapamide combination in the first-line treatment of hypertension and end-organ protection.
Gosse P
Expert Rev Cardiovasc Ther; 2006 May; 4(3):319-33. PubMed ID: 16716093
[TBL] [Abstract][Full Text] [Related]
12. [Suppression of angiotensin-converting enzyme and myocardial ischemia].
Eliseev OM
Ter Arkh; 1999; 71(3):73-6. PubMed ID: 10234773
[No Abstract] [Full Text] [Related]
13. [PROGRESS].
Hasegawa Y
Nihon Rinsho; 2006 Aug; 64 Suppl 6():396-401. PubMed ID: 16983776
[No Abstract] [Full Text] [Related]
14. Combination therapy in the extended cardiovascular continuum: a focus on perindopril and amlodipine.
Borghi C; Morbini M; Cicero AF
J Cardiovasc Med (Hagerstown); 2015 May; 16(5):390-9. PubMed ID: 25590639
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme inhibition in cardiovascular disease: evidence with perindopril.
Ferrari R
Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):15-29. PubMed ID: 15723572
[TBL] [Abstract][Full Text] [Related]
16. Hypertension, the renin-angiotensin system and perindopril. First International Symposium on Perindopril. Paris, France, October 29, 1989.
Clin Exp Hypertens A; 1989; 11 Suppl 2():459-623. PubMed ID: 2605797
[No Abstract] [Full Text] [Related]
17. Microalbuminuria in diabetic patients.
Doyle A
Nurs Times; 1991 Jul 10-16; 87(28):43. PubMed ID: 1852640
[No Abstract] [Full Text] [Related]
18. [Comparative study of the efficacy and tolerance of perindopril, a new converting enzyme inhibitor and of atenolol, a beta blocker].
Rorive G; Creytens G; Ruhwiedel M; Van de Voorde K
Rev Med Liege; 1990 Feb; 45(2):62-8. PubMed ID: 2180020
[No Abstract] [Full Text] [Related]
19. Effects of perindopril treatment on plasma and urine of kallikrein activity and the stable metabolite of prostaglandin E2 in patients with essential hypertension.
Zacharieva S; Torbova S; Orbetzova M; Borissova AM; Andonova K; Sheitanova S
Methods Find Exp Clin Pharmacol; 1996 Apr; 18(3):205-9. PubMed ID: 8738072
[TBL] [Abstract][Full Text] [Related]
20. Criticism of Servier re perindopril.
Alliot LS
Lancet; 1996 Mar; 347(9004):832. PubMed ID: 8622362
[No Abstract] [Full Text] [Related]
[Next] [New Search]
